|
1
|
Hossain SS, Islam MS, Rahman MM, Dey S and
Mahmud K: Clinical and demographic profiles of patients diagnosed
as cough variant asthma attended at Tertiary Referral Hospital.
JNINB. 2:12016.
|
|
2
|
Kanemitsu Y, Niimi A, Matsumoto H, Iwata
T, Ito I, Oguma T, Inoue H, Tajiri T, Nagasaki T, Izuhara Y, et al:
Gastroesophageal dysmotility is associated with the impairment of
cough-specific quality of life in patients with cough variant
asthma. Allergol Int. 65:320–326. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tagaya E, Kondo M, Kirishi S, Kawagoe M,
Kubota N and Tamaoki J: Effects of regular treatment with
combination of salmeterol/fluticasone propionate and salmeterol
alone in cough variant asthma. J Asthma. 52:512–518. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tajiri T, Niimi A, Matsumoto H, Ito I,
Oguma T, Otsuka K, Takeda T, Nakaji H, Inoue H, Iwata T, et al:
Prevalence and clinical relevance of allergic rhinitis in patients
with classic asthma and cough variant asthma. Respiration.
87:211–218. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Evans DJ, Taylor DA, Zetterstrom O, Chung
KF, O'Connor BJ and Barnes PJ: A comparison of low-dose inhaled
budesonide plus theophylline and high-dose inhaled budesonide for
moderate asthma. N Engl J Med. 337:1412–1418. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bao W, Chen Q, Lin Y, Liu H, Zhao G, Chen
Z and Zhou X: Efficacy of procaterol combined with inhaled
budesonide for treatment of cough-variant asthma. Respirology. 18
(Suppl 3):53–61. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Frølund L: Efficacy of an oral
antihistamine, loratadine, as compared with a nasal steroid spray,
beclomethasone dipropionate, in seasonal allergic rhinitis. Clin
Otolaryngol Allied Sci. 16:527–531. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang X, Liu B, Lu B, Zhang Y, Wang L, Li
H, Han X and Ding D: Micro-invasive embedding combined with
montelukast sodium for children cough variant asthma: A randomized
controlled trial. Zhongguo Zhen Jiu. 37:259–264. 2017.(In Chinese).
PubMed/NCBI
|
|
9
|
Zhou X, Hong J, Cheng H, Xie J, Yang J,
Chen Q, He S, Li Y, Zhou X and Li C: Budesonide suspension
nebulization treatment in Chinese pediatric patients with cough
variant asthma: A multi-center observational study. J Asthma.
53:532–537. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Steffey EP, Mama KR, Galey FD, Puschner B
and Woliner MJ: Effects of sevoflurane dose and mode of ventilation
on cardiopulmonary function and blood biochemical variables in
horses. Am J Vet Res. 66:606–614. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei Y, Li DS, Liu JJ, Zhang J and Zhao HE:
Therapeutic effect and safety of montelukast sodium combined with
budesonide in children with cough variant asthma: A meta analysis.
Zhongguo Dang Dai Er Ke Za Zhi. 18:1100–1105. 2016.(In Chinese).
PubMed/NCBI
|
|
12
|
Wang XP, Yang LD and Zhou JF: Montelukast
and budesonide combination for children with chronic cough-variant
asthma. Medicine (Baltimore). 97:e115572018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiao Q and Qin X: Effects of salmeterol
xinafoate and fluticasone propionate powder in combination with
montelukast on pulmonary function and serum inflammatory cytokines
in children with cough variant asthma. Zhongguo Jiceng Yiyao.
25:182–185. 2018.(In Chinese).
|
|
14
|
Jiao HY, Su WW, Li PB, Liao Y, Zhou Q, Zhu
N and He LL: Therapeutic effects of naringin in a guinea pig model
of ovalbumin-induced cough-variant asthma. Pulm Pharmacol Ther.
33:59–65. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takemura M, Niimi A, Matsumoto H, Ueda T,
Yamaguchi M, Matsuoka H, Jinnai M, Chin K and Mishima M: Atopic
features of cough variant asthma and classic asthma with wheezing.
Clin Exp Allergy. 37:1833–1839. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saito N, Itoga M, Tamaki M, Yamamoto A and
Kayaba H: Cough variant asthma patients are more depressed and
anxious than classic asthma patients. J Psychosom Res. 79:18–26.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dicpinigaitis PV: Chronic cough due to
asthma: ACCP evidence-based clinical practice guidelines. Chest.
129 (Suppl 1):75S–79S. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Usta Guc B, Asilsoy S and Durmaz C: The
assessment and management of chronic cough in children according to
the British Thoracic Society guidelines: Descriptive, prospective,
clinical trial. Clin Respir J. 8:330–337. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Matsuse H and Kohno S: Leukotriene
receptor antagonists pranlukast and montelukast for treating
asthma. Expert Opin Pharmacother. 15:353–363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun LH, Chen AH and Zhang Y: Therapeutic
efficacy and follow-up study of inhaled corticosteroids vs. oral
montelukast in treatment of cough variant asthma. Zhonghua Er Ke Za
Zhi. 46:85–88. 2008.(In Chinese). PubMed/NCBI
|
|
21
|
Peng QF and Kong LF: The levels of nerve
growth factor and IL-4 in induced sputum and characteristics of
airway inflammation in cough variant asthma. Zhonghua Nei Ke Za
Zhi. 50:221–224. 2011.(In Chinese). PubMed/NCBI
|
|
22
|
Fujimura M, Ogawa H, Nishizawa Y and Nishi
K: Comparison of atopic cough with cough variant asthma: Is atopic
cough a precursor of asthma? Thorax. 58:14–18. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sanchis J, Gich I and Pedersen S; Aerosol
Drug Management Improvement Team (ADMIT), : Systematic review of
errors in inhaler use: Has patient technique improved over time?
Chest. 150:394–406. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Deuse T, Hua X, Stubbendorff M, Spin JM,
Neofytou E, Taylor V, Chen Y, Park G, Fink JB, Renne T, et al: The
selective JAK1/3-inhibitor R507 mitigates obliterative airway
disease both with systemic administration and aerosol inhalation.
Transplantation. 100:1022–1031. 2016. View Article : Google Scholar : PubMed/NCBI
|
